2022
DOI: 10.1016/j.artd.2022.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Limiting the Surveillance Period to 90 Days Misses a Large Portion of Infections in the First Year After Total Hip and Knee Arthroplasty

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(15 citation statements)
references
References 25 publications
0
15
0
Order By: Relevance
“…The JBI quality assessment showed that 6 [ 13 18 ] studies had a high risk bias, 8 [ 12 , 19 25 ] studies had a moderate risk bias, and 2 [ 14 , 26 ] studies had a low risk bias. The whole process was done by two researchers.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The JBI quality assessment showed that 6 [ 13 18 ] studies had a high risk bias, 8 [ 12 , 19 25 ] studies had a moderate risk bias, and 2 [ 14 , 26 ] studies had a low risk bias. The whole process was done by two researchers.…”
Section: Resultsmentioning
confidence: 99%
“…2 and 3 . Estimates for the medical database-base studies [ 11 15 , 19 – 22 , 26 ] ranged from 0.34 to 2.45% (Fig. 2 ), and the random-effects overall pooled estimated incidence of PJI was 1.05% (95% CI 0.75–1.46%), with very high heterogeneity ( I 2 = 99.6%; heterogeneity test P = 0).…”
Section: Resultsmentioning
confidence: 99%
“…The primary outcome was the 1-year revision rate for PJI, since a 2022 study from the US reported that limiting surveillance to 3 months misses more than 40% of infections in the first year after TKA. 33 Secondary outcomes were revision for PJI or all causes at 3 months and 1, 5, and 10 years.…”
Section: Outcome Variablesmentioning
confidence: 99%
“…Muscatelli et al report that limiting infection surveillance data out to only 90 days misses 23.22% of primary total hip infections and 42.33% of primary knee infections, with similar proportions reported for revisions [7]. They suggested that extension of surveillance period is a quality improvement opportunity [7]. Zalikha et al report that the "December effect" exists for arthroplasty, in that outcomes are better in this month than in others [8].…”
mentioning
confidence: 99%
“…In an interesting viewpoint article, Roof et al discuss the "hidden cost" of revisions [6], suggesting that a shift of revisions to centers of excellence may help cost and that aligning the work involved to the reimbursement would help incentive. Muscatelli et al report that limiting infection surveillance data out to only 90 days misses 23.22% of primary total hip infections and 42.33% of primary knee infections, with similar proportions reported for revisions [7]. They suggested that extension of surveillance period is a quality improvement opportunity [7].…”
mentioning
confidence: 99%